S. Otomo

NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro

Nobuko Futaki, Satoru Takahashi, Motofumi Yokoyama et al. · Prostaglandins · 1994 · 830 citations

Inflammation, Anti-inflammatory, Biochemistry +9

Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation

Nobuko Futaki, Iwao Arai, Y Hamasaka et al. · Journal of Pharmacy and Pharmacology · 1993 · 154 citations

Inflammatory Lung Disease, Lung Inflammation, Immunology +17

Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages.

Kei Takeshita, IZUMI YAMAGISHI, Minouru Harada et al. · PubMed · 1989 · 93 citations

Immunology, Immune Regulation, Anti-inflammatory Effects +17

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Changes in locomotor activity and passive avoidance task performance induced by cerebral ischemia in Mongolian gerbils.

Yasuko Karasawa, Hiroaki Araki, S. Otomo · Stroke · 1994 · 56 citations